AdvanSix (NYSE:ASIX) Stock Price Up 1.5% – What’s Next?

AdvanSix Inc. (NYSE:ASIX) shares traded up 1.5% on Thursday . The company traded as high as $30.35 and last traded at $30.35. 10,742 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 141,037 shares. The stock had previously closed at $29.91.

Wall Street Analyst Weigh In

ASIX has been the topic of a number of recent analyst reports. Piper Sandler upped their price target on shares of AdvanSix from $35.00 to $39.00 and gave the stock an “overweight” rating in a research note on Friday, November 8th. StockNews.com cut AdvanSix from a “buy” rating to a “hold” rating in a research report on Tuesday.

AdvanSix Price Performance

The company has a quick ratio of 0.62, a current ratio of 1.34 and a debt-to-equity ratio of 0.28. The business’s 50 day moving average price is $29.73 and its 200-day moving average price is $26.94. The company has a market cap of $827.03 million, a PE ratio of 21.66 and a beta of 1.69.

AdvanSix Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend is Tuesday, November 12th. AdvanSix’s dividend payout ratio is presently 45.39%.

Insider Buying and Selling at AdvanSix

In other news, insider Christopher Gramm sold 2,435 shares of AdvanSix stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $32.00, for a total value of $77,920.00. Following the transaction, the insider now owns 43,463 shares of the company’s stock, valued at $1,390,816. The trade was a 5.31 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Erin N. Kane sold 5,000 shares of AdvanSix stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $30.28, for a total transaction of $151,400.00. Following the completion of the transaction, the chief executive officer now owns 522,795 shares in the company, valued at approximately $15,830,232.60. This trade represents a 0.95 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,418 shares of company stock worth $411,626. 5.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On AdvanSix

A number of institutional investors have recently modified their holdings of ASIX. Barclays PLC lifted its stake in shares of AdvanSix by 319.2% in the 3rd quarter. Barclays PLC now owns 42,952 shares of the company’s stock valued at $1,305,000 after purchasing an additional 32,706 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of AdvanSix by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 598,485 shares of the company’s stock valued at $18,186,000 after purchasing an additional 8,903 shares during the last quarter. Public Employees Retirement System of Ohio boosted its stake in AdvanSix by 29.9% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 6,067 shares of the company’s stock valued at $184,000 after purchasing an additional 1,396 shares during the period. Jane Street Group LLC raised its stake in AdvanSix by 162.8% during the 3rd quarter. Jane Street Group LLC now owns 51,513 shares of the company’s stock valued at $1,565,000 after purchasing an additional 31,915 shares during the last quarter. Finally, Wellington Management Group LLP grew its position in AdvanSix by 48.6% during the third quarter. Wellington Management Group LLP now owns 469,685 shares of the company’s stock worth $14,269,000 after buying an additional 153,686 shares in the last quarter. Institutional investors and hedge funds own 86.39% of the company’s stock.

AdvanSix Company Profile

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.